Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2550 of 3270 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 02/01/53
Due: 02/01/54
Phase: N/A
Priority: Normal
Start: 10/27/17
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 10/31/27
Due: 10/31/28
Phase: N/A
Priority: Normal
Start: 11/15/24
End: 11/14/27
Due: 11/14/28
Phase: N/A
Priority: Normal
Start: 04/04/24
End: 04/04/26
Due: 04/04/27
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 02/03/21
End: 10/31/21
Due: 10/31/22
Phase: N/A
Priority: Normal
Start: 03/02/16
End: 11/28/17
Due: 11/28/18
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 08/08/24
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 09/14/18
End: 08/18/21
Due: 08/18/22
Phase: N/A
Priority: Normal
Start: 03/02/18
End: 10/10/21
Due: 10/10/22
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 01/09/17
End: 09/15/20
Due: 09/15/21
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 09/20/20
Due: 09/20/21
Phase: N/A
Priority: Normal
Start: 01/18/20
End: 12/23/22
Due: 12/23/23
Phase: N/A
Priority: Normal
Start: 10/14/21
End: 01/14/22
Due: 01/14/23
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 11/30/21
End: 03/31/24
Due: 03/31/25
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 02/28/17
Due: 02/28/18